ATE121743T1 - Pyridazinon-derivate. - Google Patents

Pyridazinon-derivate.

Info

Publication number
ATE121743T1
ATE121743T1 AT90305015T AT90305015T ATE121743T1 AT E121743 T1 ATE121743 T1 AT E121743T1 AT 90305015 T AT90305015 T AT 90305015T AT 90305015 T AT90305015 T AT 90305015T AT E121743 T1 ATE121743 T1 AT E121743T1
Authority
AT
Austria
Prior art keywords
compounds
pyrido
pyridazine
oxo
substituted
Prior art date
Application number
AT90305015T
Other languages
English (en)
Inventor
Banavara Lakshmana Mylari
William James Zembrowski
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of ATE121743T1 publication Critical patent/ATE121743T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Reproductive Health (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
AT90305015T 1989-05-11 1990-05-10 Pyridazinon-derivate. ATE121743T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/350,417 US4996204A (en) 1989-05-11 1989-05-11 Pyrido[2,3-d]pyridazinones as aldose reductase inhibitors

Publications (1)

Publication Number Publication Date
ATE121743T1 true ATE121743T1 (de) 1995-05-15

Family

ID=23376622

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90305015T ATE121743T1 (de) 1989-05-11 1990-05-10 Pyridazinon-derivate.

Country Status (18)

Country Link
US (1) US4996204A (de)
EP (1) EP0401981B1 (de)
JP (1) JPH0631235B2 (de)
KR (1) KR920003559B1 (de)
AT (1) ATE121743T1 (de)
AU (1) AU611610B2 (de)
CA (1) CA2016326C (de)
DE (1) DE69018876T2 (de)
DK (1) DK0401981T3 (de)
ES (1) ES2071016T3 (de)
FI (1) FI93013C (de)
HU (1) HU206714B (de)
IE (1) IE66029B1 (de)
IL (1) IL94302A (de)
NO (1) NO173938C (de)
NZ (1) NZ233599A (de)
PT (1) PT93984B (de)
ZA (1) ZA903564B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4954629A (en) * 1989-05-11 1990-09-04 Pfizer Inc. Process and intermediates for the preparation of oxophthalazinyl acetic acids and analogs thereof
US5716954A (en) * 1991-10-09 1998-02-10 Syntex U.S.A. Inc. Benzopyridazinone and pyridopyridazinone compounds
JP2789134B2 (ja) * 1992-09-28 1998-08-20 ファイザー・インク． 糖尿病の合併症を制御する置換ピリミジン類
GB9314412D0 (en) * 1993-07-13 1993-08-25 Rhone Poulenc Agriculture New compositions of matter
JP3494990B2 (ja) * 1998-03-31 2004-02-09 ザ インスティテューツ フォア ファーマスーティカル ディスカヴァリー エルエルシー 置換されたインドールアルカノール酸
TNSN99224A1 (fr) 1998-12-01 2005-11-10 Inst For Pharm Discovery Inc Methodes de reduction des niveaux de glucose et triglyceride en serum et pour suppression de l'antigenese utilisant les acides la indolealkanoique
OA12413A (en) * 2000-11-30 2004-09-30 Pfizer Prod Inc Combination of GABA agonists and aldose reductase inhibitors.
ATE297902T1 (de) 2001-02-28 2005-07-15 Pfizer Prod Inc Sulfonyl-pyridazinon-derivate zur verwendung als aldose-reduktase-inhibitoren
AU2002226634B2 (en) * 2001-03-30 2007-01-25 Pfizer Products Inc. Pyridazinone aldose reductase inhibitors
CA2445871A1 (en) * 2001-04-30 2002-11-07 Pfizer Products Inc. Combinations of aldose reductase inhibitors and cyclooxygenase-2 inhibitors
AU761191B2 (en) 2001-05-24 2003-05-29 Pfizer Products Inc. Therapies for tissue damage resulting from ischemia
US7572910B2 (en) * 2003-02-20 2009-08-11 Pfizer, Inc. Pyridazinone aldose reductase inhibitors
US8916563B2 (en) 2010-07-16 2014-12-23 The Trustees Of Columbia University In The City Of New York Aldose reductase inhibitors and uses thereof
HUE031506T2 (en) * 2010-07-16 2017-07-28 Univ Columbia Aldose reductase inhibitors and their use
HRP20231563T1 (hr) 2016-06-21 2024-03-15 The Trustees Of Columbia University In The City Of New York 4-okso-3,4-dihidrotino[3,4-d]piridazinski spojevi kao inhibitori aldosoreduktaze i načini njihove upotrebe
MX2020001057A (es) 2017-07-28 2020-11-24 Applied Therapeutics Inc Composiciones y metodos para tratar la galactosemia.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3821383A (en) * 1972-07-10 1974-06-28 Ayerst Mckenna & Harrison Compositions for and a method of treating diabetic complications
DE2708187A1 (de) * 1977-02-25 1978-08-31 Thomae Gmbh Dr K Neue pyrido-pyridazin-one
IE47592B1 (en) * 1977-12-29 1984-05-02 Ici Ltd Enzyme inhibitory phthalazin-4-ylacetic acid derivatives, pharmaceutical compositions thereof,and process for their manufacture
US4209527A (en) * 1979-05-16 1980-06-24 Pfizer Inc. Benzimidazolone derivatives
CA1160518A (en) * 1979-07-06 1984-01-17 E. I. Du Pont De Nemours And Company Coated cookware with fep topcoat
DE3684410D1 (de) * 1985-11-07 1992-04-23 Pfizer Heterocyclische oxophthalazinylessigsaeure.
US4954629A (en) * 1989-05-11 1990-09-04 Pfizer Inc. Process and intermediates for the preparation of oxophthalazinyl acetic acids and analogs thereof

Also Published As

Publication number Publication date
NO902070L (no) 1990-11-12
FI902335A0 (fi) 1990-05-10
DK0401981T3 (da) 1995-09-04
EP0401981B1 (de) 1995-04-26
AU5490590A (en) 1990-11-15
HU206714B (en) 1992-12-28
IE901701L (en) 1990-11-11
PT93984B (pt) 1996-11-29
HUT54683A (en) 1991-03-28
NO173938B (no) 1993-11-15
KR900018092A (ko) 1990-12-20
EP0401981A1 (de) 1990-12-12
JPH035481A (ja) 1991-01-11
PT93984A (pt) 1991-01-08
US4996204A (en) 1991-02-26
FI93013B (fi) 1994-10-31
IE66029B1 (en) 1995-11-29
IL94302A (en) 1994-01-25
KR920003559B1 (ko) 1992-05-04
AU611610B2 (en) 1991-06-13
ZA903564B (en) 1992-08-26
FI93013C (fi) 1995-02-10
ES2071016T3 (es) 1995-06-16
HU902996D0 (en) 1990-09-28
DE69018876T2 (de) 1995-08-24
NO902070D0 (no) 1990-05-10
DE69018876D1 (de) 1995-06-01
IL94302A0 (en) 1991-03-10
NO173938C (no) 1994-02-23
CA2016326C (en) 1995-05-30
JPH0631235B2 (ja) 1994-04-27
NZ233599A (en) 1991-07-26
CA2016326A1 (en) 1990-11-11

Similar Documents

Publication Publication Date Title
GR3000854T3 (en) Indolinone derivatives
ATE121743T1 (de) Pyridazinon-derivate.
IL60751A (en) 6-(2'-((substituted phenyl)ethyl and-ethenyl)-4-hydroxy-tetrahydro-2h-pyran-2-one derivatives,their preparation and pharmaceutical compositions containing them
IE801005L (en) Benzimidazolones.
EP0266102A3 (en) Quinoxalinone derivatives quinoxalinone derivatives
HUT62855A (en) Process for producing glycerol derivatives and pharmaceutical compositions comprising same
AU3077289A (en) Process for the production of phthalazineacetic acid ester derivatives and a novel intermediate

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee